FDA Misses Congressionally Mandated Deadline to Publish Cannabinoid Lists

Source: https://www.marijuanamoment.net/fda-misses-deadline-to-publish-cannabinoid-list-and-define-hemp-containers-drawing-industry-criticism

Overview

The FDA has missed its Feb 10 deadline to publish lists of naturally occurring cannabinoids, THC-class compounds, and those with ‘similar effects.’ The lists were mandated by Congress under the Nov 2025 spending bill. HHS told reporters it intended to meet the deadline, but nothing has materialized. Industry stakeholders say this is more reason for Congress to delay the November hemp ban.

Clinical Perspective

💊 FDA MISSES CANNABINOID DEADLINE

The most important date for the hemp industry just passed—and the FDA didn’t deliver.

💊 Cannabinoid classification lists: NOT published

🔹 ‘Container’ definition: NOT clarified

💊 THC-class compound list: NOT released

🔹 ‘Similar effects’ guidance: NOT issued

🔹 What this means:

📈 The entire hemp industry is operating without federal clarity

🦴 Nov 2026 ban approaches with no guidance on compliance

⚖️ Stakeholders demand Congress delay implementation

HHS said they intended to meet the deadline. They didn’t. The silence speaks volumes.